Overweight and obese perimenopausal and postmenopausal women exhibit increased abnormal mammary epithelial cytology

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 3, 2007, Pages 613-616

  Seewaldt, Victoria L ^a,b   Goldenberg, Vanessa ^a   Jones, Lee W ^a,b   Peace, Charlotte ^a   Broadwater, Gloria ^b   Scott, Victoria ^a   Bean, Gregory R ^a   Wilke, Lee Gravit ^a   Zalles, Carola M ^c   Demark Wahnefried, Wendy ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CANCER INSTITUTE   (United States)

^c YALE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BODY MASS; BREAST CANCER; BREAST EPITHELIUM; CANCER RISK; CELL COUNT; CLIMACTERIUM; CONTROLLED STUDY; CYTOLOGY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; SCORING SYSTEM;

ADULT; AGED; BIOPSY, FINE-NEEDLE; BODY MASS INDEX; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; MIDDLE AGED; OBESITY; OVERWEIGHT; PERIMENOPAUSE; POSTMENOPAUSE; RISK FACTORS;

EID: 34047268880     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0878     Document Type: Article

References (15)

1. Freedman AN, Graubard BI, Rao SR, McCaskill-Stevens W, Ballard-Barbash R, Gail MH. Estimates of the number of U S. women who could benefit from tamoxifen for breast cancer chemoprevention. J Natl Cancer Inst 2003;95:526-32.
2. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U S. adults. N Engl J Med 2003;348:1625-38.
3. Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol 2005;23:1370-8.
4. Lahmann PH, Hoffmann K, Allen N, et al. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer 2004;111:762-71.
5. Morimoto LM, White E, Chen Z, et al. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Contr 2002;13:741-51.
6. World Health Organization (200). IARC Handbook of Cancer Prevention (ISSN 1027-5622) Vol. 6 Lyon, France: IARC Press.
7. Boyd NF, Rommens JM, Vogt K. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 2005;6:798-808.
8. McTiernan A. Obesity and cancer: the risks, science, and potential management strategies. Oncology (Huntingt) 2005;19:871-81.
9. Fabian CJ, Kimler BF, Zalles CM, et al. Short-term breast cancer prediction by random preiareolar fine-needle aspiration cytology and the Gail risk model. J Natl Cancer Inst 2000;92:1217-27.
10. Fabian CJ, Kimler BF, Brady DA, et al. A phase II breast cancer chemoprevention trial of oral difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkers. Clin Cancer Res 2002;8:3105-17.
11. Bean GR, Scott V, Yee L, et al. Retinoic acid receptor-β2 promoter methylation in random periareolar fine needle aspiration. Cancer Epidemiol Biomarkers Prev 2005;14:790-8.
12. National Cancer Institute. Breast cancer assessment tool. Avaialble from: http://bcra.nci.nih.gov.
13. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Am J Clin Nutr 1998;68:899-917.
14. Zalles CM, Kimler BF, Kamel S, McKittrick R, Fabian CJ. Cytology patterns in random aspirates from women at high and low risk for breast cancer. Breast J 1995;1:343-9.
15. Masood S, Frykberg ER, McLellan GL, Scalapino MC, Mitchum DG, Bullard JB. Prospective evaluation of radiologically directed fine-needle aspiration biopsy of nonpalpable breast lesions. Cancer 1990;66:1480-7.